Skip to main content

Dyadic International, Inc.

corporate_fare Company Profile

Dyadic International, Inc.

DYAI·NASDAQ·Life Sciences·CIK 0001213809

Dyadic International, Inc., operating as Dyadic Applied BioSolutions, is a global biotechnology company headquartered in Jupiter, Florida, with additional operations in the United States and a satellite office in the Netherlands. The company focuses on developing, manufacturing, and commercializing precision-engineered, animal-free recombinant proteins and enzymes. These products serve applications across life sciences, food and nutrition, and bio-industrial markets. Dyadic utilizes its proprietary microbial expression platforms, including the C1 and Dapibus™ systems, to produce these recombinant proteins. These platforms are designed for scalable and cost-effective production for use in research, diagnostics, cell culture, nutrition, and industrial biotechnology. The company collaborates with third-party consultants, contract research organizations, and manufacturing partners for specific research, development, and commercial activities. Dyadic's commercialization strategy involves direct product sales, distribution partnerships, manufacturing collaborations, and technology licensing agreements. These agreements can include annual licensing fees, milestone payments, development funding, product supply revenues, and revenue-sharing. For over two decades, Dyadic developed a gene expression platform based on the Thermothelomyces heterothallica fungus, named the C1 platform, for producing industrial enzymes and proteins. Historically, this technology was licensed to third parties like Abengoa Bioenergy, BASF SE, and Codexis, Inc., for non-pharmaceutical industrial applications. Following the sale of certain industrial technology assets to Danisco USA (DuPont's industrial biosciences business), Dyadic retained rights to sublicense the C1 platform for human and animal pharmaceutical applications, with some exceptions, and may receive royalties from commercialized products. Post-DuPont transaction, Dyadic has focused on advancing the C1 platform for pharmaceutical uses, including vaccines and monoclonal antibodies.

Dyadic International, Inc. (NASDAQ:DYAI) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 31 items for DYAI at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-13, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 14 rated 8 or above. Recent SEC coverage for DYAI spans 10-Q, 8-K, 424B5, DEFA14A.

Recent high-impact activity:

  • Dyadic 10-Q: Going Concern Reaffirmed, Cash Funds Operations Only ~7 Months
  • Q3 Revenue Drops 61.4% to $449.1K as Dyadic Flags Going-Concern Doubt
  • Dyadic Faces Two Nasdaq Delisting Notices Over Bid Price and Market Value Shortfalls
  • Dyadic H1 Revenue Up 52% But Losses Widen; $2.9M Share Sale to Fund Operations
  • Dyadic Prices $2.9M Registered Direct Offering with Warrants at $0.795/Share

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$3.09M
Net Income
-$7.36M
Diluted EPS
-$0.23
Op. Cash Flow
-$5.7M
Gross Profit
$770.49K
Operating Income
-$7.19M
Cash & Equivalents
$4.62M
Debt / Equity
0.00×
Net Margin
-238.3%
Shares Outstanding
36.19M sh
Source: 10-K · filed 2026-04-30 · accession 0001493152-26-020402

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 83,236 shares in DYAI as of the October 30, 2026 settlement, a 57.3% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 71.0% of DYAI volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)83,236 shares as of October 30, 2026
Change vs prior period▼ 57.3%
Days to cover1.00 at avg daily volume of 83,778
Daily short volume (FINRA facilities)71.0% of 52,132 shares on November 20, 2026
5-day average short volume50.7%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Low risk

Filing-implied dilution signals for DYAI, detected from its recent SEC filings · based on capital-structure filings through 2026-08-13.

1 recent capital raise1 shelf registration

Registered Direct Offering Priced · Concurrent Warrant Placement

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with D →
$0.3305 +15.16% today
52-week range · as of 2026-11-13 $0.315 – $1.6
Market cap
$11.51M
Volume
85.4K (0.9× avg)
3-mo avg 94.8K
Live data · 2026-11-22 12:43 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed DYAI - Latest Insights

DYAI
Nov 13, 2026, 4:00 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.327
Real-time Price: $0.3305 info
Change: +$0.0035 (+1%) info
Market Cap: $11.506M info
DYAI
Nov 12, 2026, 4:05 PM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $0.3501
Real-time Price: $0.3305 info
Change: -$0.0196 (-6%) info
Market Cap: $11.506M info
DYAI
Sep 25, 2026, 5:27 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.4198
Real-time Price: $0.3305 info
Change: -$0.0893 (-21%) info
Market Cap: $11.506M info
DYAI
Aug 17, 2026, 7:27 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $0.710
Real-time Price: $0.3305 info
Change: -$0.3795 (-53%) info
Market Cap: $11.506M info
DYAI
Aug 14, 2026, 9:17 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.7702
Real-time Price: $0.3305 info
Change: -$0.4397 (-57%) info
Market Cap: $11.506M info
DYAI
Aug 13, 2026, 5:25 PM EDT
Filing Type: 424B5
Importance Score:
8
Price at Filing: $0.7854
Real-time Price: $0.3305 info
Change: -$0.4549 (-58%) info
Market Cap: $11.506M info
DYAI
Aug 13, 2026, 8:01 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $0.8492
Real-time Price: $0.3305 info
Change: -$0.5187 (-61%) info
Market Cap: $11.506M info
DYAI
Aug 12, 2026, 8:45 AM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $1.00
Real-time Price: $0.3305 info
Change: -$0.6695 (-67%) info
Market Cap: $11.506M info
DYAI
Aug 12, 2026, 8:45 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.00
Real-time Price: $0.3305 info
Change: -$0.6695 (-67%) info
Market Cap: $11.506M info
DYAI
Aug 12, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.00
Real-time Price: $0.3305 info
Change: -$0.6695 (-67%) info
Market Cap: $11.506M info
DYAI
Jul 24, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.23
Real-time Price: $0.3305 info
Change: -$0.8995 (-73%) info
Market Cap: $11.506M info
DYAI
Jul 07, 2026, 7:25 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.965
Real-time Price: $0.3305 info
Change: -$0.6345 (-66%) info
Market Cap: $11.506M info
DYAI
Jun 22, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.7976
Real-time Price: $0.3305 info
Change: -$0.4671 (-59%) info
Market Cap: $11.506M info
DYAI
Jun 18, 2026, 10:03 AM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $0.865
Real-time Price: $0.3305 info
Change: -$0.5345 (-62%) info
Market Cap: $11.506M info
DYAI
Jun 18, 2026, 9:56 AM EDT
Filing Type: DEFA14A
Importance Score:
9
Price at Filing: $0.8485
Real-time Price: $0.3305 info
Change: -$0.518 (-61%) info
Market Cap: $11.506M info
DYAI
Jun 18, 2026, 9:55 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.8485
Real-time Price: $0.3305 info
Change: -$0.518 (-61%) info
Market Cap: $11.506M info
DYAI
Jun 15, 2026, 4:43 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $0.777
Real-time Price: $0.3305 info
Change: -$0.4465 (-57%) info
Market Cap: $11.506M info
DYAI
Jun 15, 2026, 7:25 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.7456
Real-time Price: $0.3305 info
Change: -$0.4151 (-56%) info
Market Cap: $11.506M info
DYAI
May 28, 2026, 9:11 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.7523
Real-time Price: $0.3305 info
Change: -$0.4218 (-56%) info
Market Cap: $11.506M info
DYAI
May 13, 2026, 4:21 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $0.708464
Real-time Price: $0.3305 info
Change: -$0.377964 (-53%) info
Market Cap: $11.506M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets